115 related articles for article (PubMed ID: 2100733)
1. Susceptibility of several species of Candida and Torulopsis to fluconazole and ketoconazole.
Mallié M; Montès B; Reynes J; Bastide JM
Drugs Exp Clin Res; 1990; 16(10):509-13. PubMed ID: 2100733
[TBL] [Abstract][Full Text] [Related]
2. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
Mallié M; Montès B; Lebecq JC; Bastide JM
Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
[TBL] [Abstract][Full Text] [Related]
4. [In vitro evaluation of the sensitivity to fluconazole of different species of yeasts isolated in pathology].
Regli P; Blancard A; Goudard M; Moulin-Traffort J; Sarzier JM; Quilici M
Pathol Biol (Paris); 1992 May; 40(5):500-6. PubMed ID: 1495834
[TBL] [Abstract][Full Text] [Related]
5. [In vitro effect of itraconazole against various species of Candida].
Bastide M; Mallie M; Jouvert S; Montes B; Bastide JM
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
[TBL] [Abstract][Full Text] [Related]
6. [Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Carrillo-Muñoz AJ; Quindós G; Gasser I; Tur-Tur C; Ruesga MT; Alonso-Vargas R; Arévalo P; Bornay-Llinares FJ; Santos P; del Valle O
Rev Esp Quimioter; 1999 Jun; 12(2):126-35. PubMed ID: 10562673
[TBL] [Abstract][Full Text] [Related]
7. [CHROMAgar Candida with fluconazole: comparison with microdilution techniques].
Linares MJ; Charriel G; Solís F; Casal M
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):493-7. PubMed ID: 14572382
[TBL] [Abstract][Full Text] [Related]
8. [Biofilm production and antifungal susceptibility patterns of Candida species].
Yücesoy M; Karaman M
Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Martín E; Parras P; Lozano MC
Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Morace G; Manzara S; Dettori G
Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
[TBL] [Abstract][Full Text] [Related]
12. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
13. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
14. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
Guinet R; Marlier H
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
[TBL] [Abstract][Full Text] [Related]
15. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
[TBL] [Abstract][Full Text] [Related]
16. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
Lombardi G; Gramegna G; Cavanna C; Michelone G
Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility of Candida species to five antifungal agents in a German university hospital assessed by the reference broth microdilution method and Etest.
Fleck R; Dietz A; Hof H
J Antimicrob Chemother; 2007 Apr; 59(4):767-71. PubMed ID: 17293369
[TBL] [Abstract][Full Text] [Related]
18. [Vaginal candidiasis: etiology and sensitivity profile to antifungal agents in clinical use].
Saporiti AM; Gómez D; Levalle S; Galeano M; Davel G; Vivot W; Rodero L
Rev Argent Microbiol; 2001; 33(4):217-22. PubMed ID: 11833253
[TBL] [Abstract][Full Text] [Related]
19. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
20. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines.
Testore GP; Dori L; Buonomini AR; Schito GC; Soro O; Fortina G; Andreoni S; Carlone N; Tullio V; Andreoni M
Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
